MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,826,229
EPS
-$0.09
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
-
-
405,486*
1,232,938
Research and development
1,476,161
2,842,728
5,174,239.75*
2,345,843
General and administrative
1,144,205
1,229,807
1,231,330*
1,023,821
Loss on early termination of vendor agreement
-
-
-113,283.75*
-
Total operating expenses
2,620,366
4,072,535
6,518,853.5*
3,369,664
Loss from operations
-2,620,366
-4,072,535
-6,113,367.5*
-2,136,726
Grant income
681,579
751,691
-
-
Interest income
112,558
132,889
195,072.5*
138,064
Other income
-
8,677
-234,888*
-
Loss from operations before income taxes
-
-
-6,153,183*
-
Income tax (benefit) expense
-
-
-3,789*
-
Net loss
-1,826,229
-3,179,278
-6,149,394
-1,998,662
Basic EPS
-0.09
-0.16
-0.402
-0.12
Diluted EPS
-0.09
-0.16
-0.402
-0.12
Basic Average Shares
19,314,742
19,314,742
15,310,308*
16,757,678
Diluted Average Shares
19,314,742
19,314,742
15,310,308*
16,757,678
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$1,826,229
(54.52%↑ Y/Y)
Grant income
$681,579
Interest income
$112,558
(-12.08%↓ Y/Y)
Loss from operations
-$2,620,366
(38.50%↑ Y/Y)
Total operating
expenses
$2,620,366
(-48.84%↓ Y/Y)
Research and development
$1,476,161
(-64.66%↓ Y/Y)
General and
administrative
$1,144,205
(21.06%↑ Y/Y)
Buy us a coffee
Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc. (MRKR)